Ernst & Young has ranked the Swiss biotech industry as one of the top in Europe on product development, turnover and market capitalization. This success can largely be attributed to biotech clusters developed in the Basel, Geneva, and Zurich areas. The Zurich MedNet is comprised of more than 400 companies, universities, institutes, foundations, hospitals and labs making it the single largest medical/biotech cluster in continental Europe.
Send to e-mail address:*
From e-mail address:*
Your comment to this article:
* Required fields